BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30322160)

  • 21. Epigallocatechin gallate alters leukotoxin secretion and Aggregatibacter actinomycetemcomitans virulence.
    Chang EH; Brown AC
    J Pharm Pharmacol; 2021 Mar; 73(4):505-514. PubMed ID: 33793838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomics of Aggregatibacter actinomycetemcomitans Outer Membrane Vesicles.
    Kieselbach T; Zijnge V; Granström E; Oscarsson J
    PLoS One; 2015; 10(9):e0138591. PubMed ID: 26381655
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Lally ET; Boesze-Battaglia K; Dhingra A; Gomez NM; Lora J; Mitchell CH; Giannakakis A; Fahim SA; Benz R; Balashova N
    Pathogens; 2020 Jan; 9(2):. PubMed ID: 31973183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenicity of the highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans and its geographic dissemination and role in aggressive periodontitis.
    Haubek D; Johansson A
    J Oral Microbiol; 2014; 6():. PubMed ID: 25206940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxin-triggered liposomes for the controlled release of antibiotics to treat infections associated with the gram-negative bacterium, Aggregatibacter actinomycetemcomitans.
    Li Z; Baidoun R; Brown AC
    Colloids Surf B Biointerfaces; 2024 Jun; 238():113870. PubMed ID: 38555763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catechin-mediated restructuring of a bacterial toxin inhibits activity.
    Chang EH; Huang J; Lin Z; Brown AC
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):191-198. PubMed ID: 30342156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans.
    Crosby JA; Kachlany SC
    Gene; 2007 Feb; 388(1-2):83-92. PubMed ID: 17116373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aggregatibacter actinomycetemcomitans leukotoxin induces cytosol acidification in LFA-1 expressing immune cells.
    Balashova N; Dhingra A; Boesze-Battaglia K; Lally ET
    Mol Oral Microbiol; 2016 Feb; 31(1):106-14. PubMed ID: 26361372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy.
    Kachlany SC
    J Dent Res; 2010 Jun; 89(6):561-70. PubMed ID: 20200418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukotoxin (Leukothera®) targets active leukocyte function antigen-1 (LFA-1) protein and triggers a lysosomal mediated cell death pathway.
    DiFranco KM; Gupta A; Galusha LE; Perez J; Nguyen TK; Fineza CD; Kachlany SC
    J Biol Chem; 2012 May; 287(21):17618-17627. PubMed ID: 22467872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational modeling and druggability assessment of Aggregatibacter actinomycetemcomitans leukotoxin.
    Hakmi M; Bouricha EM; El Harti J; Amzazi S; Belyamani L; Khanfri JE; Ibrahimi A
    Comput Methods Programs Biomed; 2022 Jul; 222():106952. PubMed ID: 35724475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Bacterial Toxin Activity by the Nuclear Stain, DRAQ5™.
    Webb JN; Koufos E; Brown AC
    J Membr Biol; 2016 Aug; 249(4):503-11. PubMed ID: 27039399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cranberry Proanthocyanidins Neutralize the Effects of
    Ben Lagha A; Howell A; Grenier D
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31739483
    [No Abstract]   [Full Text] [Related]  

  • 34. Identifying size-dependent toxin sorting in bacterial outer membrane vesicles.
    Singh AN; Nice JB; Brown AC; Wittenberg NJ
    bioRxiv; 2023 May; ():. PubMed ID: 37205353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of Aggregatibacter (Actinobacillus) actinomycetemcomitans leukotoxin secretion by iron.
    Balashova NV; Diaz R; Balashov SV; Crosby JA; Kachlany SC
    J Bacteriol; 2006 Dec; 188(24):8658-61. PubMed ID: 17041062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification of secreted leukotoxin (LtxA) from Actinobacillus actinomycetemcomitans.
    Kachlany SC; Fine DH; Figurski DH
    Protein Expr Purif; 2002 Aug; 25(3):465-71. PubMed ID: 12182827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukotoxin from Aggregatibacter actinomycetemcomitans causes shrinkage and P2X receptor-dependent lysis of human erythrocytes.
    Munksgaard PS; Vorup-Jensen T; Reinholdt J; Söderström CM; Poulsen K; Leipziger J; Praetorius HA; Skals M
    Cell Microbiol; 2012 Dec; 14(12):1904-20. PubMed ID: 22906303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes.
    DiFranco KM; Johnson-Farley N; Bertino JR; Elson D; Vega BA; Belinka BA; Kachlany SC
    Leuk Res; 2015 Jun; 39(6):649-56. PubMed ID: 25850729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aggregatibacter (Actinobacillus) actimycetemcomitans leukotoxin and human periodontitis - A historic review with emphasis on JP2.
    Tsai CC; Ho YP; Chou YS; Ho KY; Wu YM; Lin YC
    Kaohsiung J Med Sci; 2018 Apr; 34(4):186-193. PubMed ID: 29655406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multivariate Analysis of Individual Bacterial Outer Membrane Vesicles Using Fluorescence Microscopy.
    Singh AN; Nice JB; Wu M; Brown AC; Wittenberg NJ
    Chem Biomed Imaging; 2024 May; 2(5):352-361. PubMed ID: 38817321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.